Dextrose (Pitman-Moore) New Zealand - English - Medsafe (Medicines Safety Authority)

dextrose (pitman-moore)

pitman-moore new zealand ltd - glucose 10%{relative} (and 15%, 25%) - solution for infusion - 10%, 15%, 25%w/v - active: glucose 10%{relative} (and 15%, 25%)

GLUCOSE 10 % Israel - English - Ministry of Health

glucose 10 %

lapidot medical import and marketing ltd - glucose as monohydrate - solution for infusion - glucose as monohydrate 10 % - glucose - glucose - carbohydrate infusion therapy : - hypoglycaemic situations, - hypertonic dehydration , - hypertonic electrolyte disturbances. vehicle solution for supplementary medication.

Glucose 10 % w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 10 % w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Glucose 10 % w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 10 % w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Glucose 10 % w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 10 % w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Glucose 10 % w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 10 % w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Glucose 10 % w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 10 % w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/weight - solutions for parenteral nutrition; carbohydrates

ZYTIGA- abiraterone acetate tablet ZYTIGA- abiraterone acetate tablet, film coated United States - English - NLM (National Library of Medicine)

zytiga- abiraterone acetate tablet zytiga- abiraterone acetate tablet, film coated

janssen biotech, inc. - abiraterone acetate (unii: em5ocb9yj6) (abiraterone - unii:g819a456d0) - abiraterone acetate 250 mg - zytiga is indicated in combination with prednisone for the treatment of patients with - metastatic castration-resistant prostate cancer (crpc) - metastatic high-risk castration-sensitive prostate cancer (cspc) none. risk summary the safety and efficacy of zytiga have not been established in females. based on findings from animal studies and the mechanism of action, zytiga can cause fetal harm and potential loss of pregnancy. there are no human data on the use of zytiga in pregnant women. in animal reproduction studies, oral administration of abiraterone acetate to pregnant rats during organogenesis caused adverse developmental effects at maternal exposures approximately ≥ 0.03 times the human exposure (auc) at the recommended dose (see data). data animal data in an embryo-fetal developmental toxicity study in rats, abiraterone acetate caused developmental toxicity when administered at oral doses of 10, 30 or 100 mg/kg/day throughout the period of organogenesis (gestational days 6–17). findings included embryo

Glucose 10% w/v Solution for Infusion Malta - English - Medicines Authority

glucose 10% w/v solution for infusion

baxter healthcare limited - glucose monohydrate - solution for infusion - glucose monohydrate 100 milligram(s)/millilitre - blood substitutes and perfusion solutions

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.